Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats

Ultrastructural Pathology

Volumn 41, Issue 2, 2017, Pages 168-185

  Ahmed, Samah M ^a   Abdelrahman, Shaimaa Ali ^a   Salama, Alaa Elsayed ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Echocardiography; energy dispersive X ray microanalysis; gold nanoparticles; isoproterenol; myocardial infarction

Indexed keywords

CARDIOTONIC AGENT; GOLD; ISOPRENALINE; METAL NANOPARTICLE;

ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CHEMICALLY INDUCED; DISEASE MODEL; ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; HEART INFARCTION; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; RAT; SPECTROMETRY; WISTAR RAT;

ANIMALS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GOLD; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; ISOPROTERENOL; MALE; METAL NANOPARTICLES; MICROSCOPY, ELECTRON; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; SPECTROMETRY, X-RAY EMISSION;

EID: 85014484410     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913123.2017.1281367     Document Type: Article

References (72)

1. Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ., Cardioprotection and pharmacological therapies in acute myocardial infarction:challenges in the current era. World J Cardiol. 2014;6(3):100–106.
2. Li L, Zhang LK, Chen L, Wang X, Zhang J., Cardioprotective effects of ghrelin and des‐octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol Sin. 2006;27(5):527–535.
3. Jagadeesh GS, Nagoor Meeran MF, Selvaraj P., Protective effects of 7‐hydroxycoumarin on dyslipidemia and cardiac hypertrophy in isoproterenol‐induced myocardial infarction in rats. J Biochem Mol Toxicol. 2015;30(3):120–127.
4. Neri M, Fineschi V, Di Paolo M, et al. Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr Vasc Pharmacol. 2015;13(1):26–36.
5. Kelly RA, Balligand JL, Smith TW., Nitric oxide and cardiac function. Circ Res. 1996;79:363–380.
6. Tamargo J, Caballero R, Gomez R, Delpon E., Cardiac electrophysiological effects of nitric oxide. Cardiovasc Res. 2010;87:593–600.
7. Jones SP, Greer JJ, Kakkar AK, et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol. 2004;286:H276–H282.
8. Pott C, Steinritz D, Bolck B, et al. eNOS translocation but not eNOS phosphorylation is dependent on intracellular Ca2+ in human atrial myocardium. Am J Physiol Cell Physiol. 2006;290:C1437–C1445.
9. Crespo MJ, Zalacaín J, Dunbar DC, Cruz N, Arocho L., Cardiac oxidative stress is elevated at the onset of dilated cardiomyopathy in streptozotocin-diabetic rats. J Cardiovasc Pharmacol Ther. 2008;13(1):64–71.
10. Spivak MY, Bubnov RV, Yemets IM, Lazarenko LM, Tymoshok NO, Ulberg ZR., Development and testing of gold nanoparticles for drug delivery and treatment of heart failure:a theranostic potential for PPP cardiology. EPMA J. 2013;4(1):1.
11. Huang X, El-Sayed MA., Gold nanoparticles:optical properties and implementations in cancer diagnosis and photothermal therapy. J Adv Res. 2010;1(1):13–28.
12. Sperling RA, Gil PR, Zhang F, Zanella M, Parak WJ., Biological applications of gold nanoparticles. Chem Soc Rev. 2008;37(9):1896–1908.
13. Haes AJ, Hall WP, Chang L, Klein WL, Van Duyne RP., A localized surface plasmon resonance biosensor:First steps toward an assay for Alzheimer’s disease. Nano Lett. 2004;4(6):1029–1034.
14. Haes AJ, Chang L, Klein WL, Van Duyne RP., Detection of a biomarker for Alzheimer’s disease from synthetic and clinical samples using a nanoscale optical biosensor. J Am Chem Soc. 2005;127(7):2264–2271.
15. Baptista PV, Koziol-Montewka M, Paluch-Oles J, Doria G, Franco R., Gold-nanoparticle-probe–based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin Chem. 2006;52(7):1433–1434.
16. Giannitrapani L, Soresi M, Bondì ML, Montalto G, Cervello M., Nanotechnology applications for the therapy of liver fibrosis. World J Gastroenterol. 2014;20(23):7242–7251.
17. Yang C, Tian A, Li Z., Reversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in mice. Sci Rep. 2016;6:20203. DOI:10.1038/srep20203.
18. Sun SJ, Wu XP, Song HL, Li GQ., Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation, oxidative stress and P38MAPK pathway in rat. Int J Clin Exp Med. 2015;8(12):22063–22072.
19. Bancroft J, Layton C., The Hematoxylin and eosin. In:Suvarna SK, Layton C, Bancroft JD, ed. Theory and Practice of Histological Techniques. 7th ed. Philadelphia:Churchill Livingstone of El Sevier, Ch. 10 and 11; 2013:172–214.
20. Drury RA, Wallington EA., Carlton’s Histological Techniques. 5th ed. Oxford:Oxford University Press; 1980.
21. Ramos-Vara JA, Kiupel M, Baszier T, et al. Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories. J Vet Diagn Invest. 2008;20:393–413.
22. Glauert AM, Lewis PR., Biological Specimen Preparation for Transmission Electron Microscopy. 1st ed. London:Portland Press; 1998.
23. Jong WH, Burger MC, Verheijen MA, Geertsma RE., Detection of the presence of gold nanoparticles in organs by transmission electron microscopy. Materials 2010;3(9):4681–4694.
24. Abozeid AA, Abou Fard GM, Shafik NM., Effect of systemic Ghrelin administration on experimental myocardial infarction induced by isoproterenol in rats. Bull Egypt Soc Physiol Sci. 2014;34(1):43–56.
25. Patel V, Upaganlawar A, Zalawadia R, Balaraman R., Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats:a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol. 2010;644(1):160–168.
26. Hussain Shaik A, Rasool SN, Kareem MA, Krushna GS, Akhtar PM, Devi KL., Maslinic acid protects against isoproterenol-induced cardiotoxicity in albino Wistar rats. J Med Food. 2012;15(8):741–746.
27. Vijayan NA, Thiruchenduran M, Devaraj SN., Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage. Mol. Cell. Biochem. 2012;367(1–2):1–8.
28. Euteneuer F, Mills PJ, Rief W, Ziegler MG, Dimsdale JE., Association of in vivo beta-adrenergic receptor sensitivity with inflammatory markers in healthy subjects. Psychosomatic Med. 2012;74(3):271.
29. Moradi-Arzeloo M, Farshid AA, Tamaddonfard E, Asri-Rezaei S., Effects of histidine and vitamin C on isoproterenol-induced acute myocardial infarction in rats. Vet Res Forum. 2016;7(1):47. Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
30. Li H, Xie YH, Yang Q, et al. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PloS One. 2012;7(11):e48872.
31. Gao Y, Hao J, Zhang H, et al. Protective effect of the combinations of glycyrrhizic, ferulic and cinnamic acid pretreatment on myocardial ischemia-reperfusion injury in rats. Exp Ther Med. 2015;9(2):435–445.
32. Mill JG, Stefanon I, dos Santos L, Baldo MP. Remodeling in the ischemic heart:the stepwise progression for heart failure. Braz J Med Biol Res 2011 Sep;44(9):890–898.
33. Rajappa M, Sen SK, Sharma A., Role of pro-/anti-inflammatory cytokines and their correlation with established risk factors in South Indians with coronary artery disease. Angiology 2009;60:419.
34. Del Monte U., Swelling of hepatocytes injured by oxidative stress suggests pathological changes related to macromolecular crowding. Med Hypotheses 2005;64(4):818–825.
35. Stanely Mainzen Prince P, Karthick M. Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol‐induced myocardial infarction in rats. J Biochem Mol Toxicol. 2007;21(1):1–6.
36. Bharti S, Arora S, Arya DS. Evaluation of morphological changes in experimental models of myocardial infarction:electron and light microscopical evidence. In:Méndez-Vilas A, Díaz J, eds. Microscopy Book Series No. 4 Volume 1, Microscopy:Science, Technology, Applications and Education. New Delhi, India:FORMATEX; 2010:361–371.
37. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD., Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1(3):325–327.
38. Zhang XD, Wu HY, Wu D, et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomed. 2010;5:771–781.
39. Abdelhalim MA., Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure. Lipids Health Dis. 2011;10(1):1.
40. Yang C, Yang H, Wu J, et al. No overt structural or functional changes associated with PEG-coated gold nanoparticles accumulation with acute exposure in the mouse heart. Toxicol Lett. 2013;222(2):197–203.
41. Abdelhalim MAK., Uptake of gold nanoparticles in several rat organs after intraperitoneal administration in vivo:a fluorescence study. Bio Med Res Int. 2013;2013. DOI:10.1155/2013/353695.
42. Burlew BS, Weber KT., Connective tissue and the heart:functional significance and regulatory mechanisms. Cardiol Clin. 2000;18(3):435–442.
43. Bisht S, Khan MA, Bekhit M, et al. A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest. 2011;91:1383–1395.
44. Toyama T, Nakamura H, Harano Y, et al. PPAR alpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun. 2004;324:697–704.
45. Chen H, He YW, Liu WQ, Zhang JH., Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. World J Gastroenterol. 2008;14:2905–2911.
46. Thakor AS, Jokerst J, Zavaleta C, Massoud TF, Gambhir SS., Gold nanoparticles:a revival in precious metal administration to patients. Nano Lett. 2011;11(10):4029–4036.
47. Khan MS, Vishakante GD, Siddaramaiah H., Gold nanoparticles:a paradigm shift in biomedical applications. Adv Colloid Interface Sci. 2013;199:44–58.
48. van Nieuwenhoven FA, Turner NA., The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vasc Pharmacol. 2013;58(3):182–188.
49. Zaitone SA, Abo-Gresha NM., Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats:role of iNOS and VEGF. Eur J Pharmacol. 2012;691(1):134–142.
50. Megson IL, Haw SJ, Newby DE, Pell JP., Association between exposure to environmental tobacco smoke and biomarkers of oxidative stress among patients hospitalised with acute myocardial infarction. PloS One. 2013;8(12):e81209.
51. Perrelli MG, Pagliaro P, Penna C., Ischemia/reperfusion injury and cardioprotective mechanisms:role of mitochondria and reactive oxygen species. World J Cardiol. 2011;3(6):186–200.
52. Garg M, Khanna D., Exploration of pharmacological interventions to prevent isoproterenol-induced myocardial infarction in experimental models. Ther Adv Cardiovasc Dis. 2014;8(4):155–169.
53. Kannan MM, Quine SD., Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats. Metabolism. 2013;62:52–61.
54. Jordan JE, Zhao ZQ, Vinten-Johansen J., The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res. 1999;43:860–878.
55. BarathManiKanth S, Kalishwaralal K, Sriram M, et al. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnol. 2010;8(1):1.
56. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M., Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment:a microscopic overview. Langmuir. 2005;21(23):10644–10654.
57. Álvaro M, Aprile C, Corma A, Ferrer B, García H., Influence of radical initiators in gold catalysis:evidence supporting trapping of radicals derived from azobis (isobutyronitrile) by gold halides. J Catal. 2007;245(1):249–252.
58. Yakimovich NO, Ezhevskii AA, Guseinov DV, Smirnova LA, Gracheva TA, Klychkov KS., Antioxidant properties of gold nanoparticles studied by ESR spectroscopy. Russ Chem Bull. 2008;57(3):520–523.
59. Nelson BC, Petersen EJ, Marquis BJ, et al. NIST gold nanoparticle reference materials do not induce oxidative DNA damage. Nanotoxicology 2013;7(1):21–29.
60. Technical Palojoki E, Saraste A, Eriksson A, et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol-Heart Circulatory Physiol. 2001;280(6):H2726–H2731.
61. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest J Tech Methods Pathol. 1996;74(1):86–107.
62. Akasaka Y, Morimoto N, Ishikawa Y, et al. Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction. Mod Pathol. 2006;19(4):588–598.
63. Tsujimoto Y., Role of Bcl‐2 family proteins in apoptosis:apoptosomes or mitochondria? Genes Cells 1998;3(11):697–707.
64. Condorelli G, Morisco C, Stassi G, et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation. 1999; 99(23):3071–3078.66- Farvin KS, Anandan R, Kumar SH, Shiny KS, Sankar TV, Thankappan TK. Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol Res. 2004;50(3):231–236.
65. Liu Q, Zhang J, Xu Y, Huang Y, Wu C., Effect of carvedilol on cardiomyocyte apoptosis in a rat model of myocardial infarction:a role for toll-like receptor 4. Indian J Pharmacol. 2013;45(5):458.
66. Liu Z, Shen Y, Wu Y, et al. An intrinsic therapy of gold nanoparticles in focal cerebral ischemia-reperfusion injury in rats. J Biomed Nanotechnol. 2013;9(6):1017–1028.
67. El-Mehy AE., Histological and immunohistochemical study on the effect of doxorubicin on the heart of adult albino rat and the possible protective role of an antioxidant beer E. El-Mehy; Fouad K. Mansour; Nariman A. Abd El-Fattah; Fatma A. El-Safty and Mohamed M. El-Fiky. MMJ. 2008;21(1):91–108.
68. Nagoor Meeran MF, Stanely Mainzen Prince P. Protective effects of N‐acetyl cysteine on membrane‐bound adenosine triphosphatases and minerals in isoproterenol‐induced myocardial‐infarcted rats:an in vivo and in vitro study. J Biochem Mol Toxicol. 2012;26(7):276–281.
69. Meeran N, Fizur M, Stanely Mainzen Prince P. Protective effects of thymol on altered plasma lipid peroxidation and nonenzymic antioxidants in isoproterenol‐induced myocardial infarcted rats. J Biochem Mol Toxicol. 2012;26(9):368–373.
70. Farvin KS, Anandan R, Kumar SH, Shiny KS, Sankar TV, Thankappan TK. Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. Pharmacol Res. 2004;50(3):231–236.
71. Thygesen K, Alpert JS, White HD., Universal definition of myocardial infarction. J Am College Cardiol. 2007;50(22):2173–2195.
72. Arya DS, Bansal P, Ojha SK, Nandave M, Mohanty I, Gupta SK. Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury. Life Sci. 2006;79(1):38–44.